APA

Wang L., Yang R., Zhao L., Zhang X., Xu T. & Cui M. (20200117). Basing on uPAR-binding fragment to design chimeric antigen receptors triggers antitumor efficacy against uPAR expressing ovarian cancer cells. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Chicago

Wang Liang, Yang Rulin, Zhao Liping, Zhang Xiwen, Xu Tianmin and Cui Manhua. 20200117. Basing on uPAR-binding fragment to design chimeric antigen receptors triggers antitumor efficacy against uPAR expressing ovarian cancer cells. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Harvard

Wang L., Yang R., Zhao L., Zhang X., Xu T. and Cui M. (20200117). Basing on uPAR-binding fragment to design chimeric antigen receptors triggers antitumor efficacy against uPAR expressing ovarian cancer cells. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

MLA

Wang Liang, Yang Rulin, Zhao Liping, Zhang Xiwen, Xu Tianmin and Cui Manhua. Basing on uPAR-binding fragment to design chimeric antigen receptors triggers antitumor efficacy against uPAR expressing ovarian cancer cells. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 20200117.